Treatment of Breast cancer??

Early breast cancer can now be treated with a lumpectomy plus radiation given on the operating table. True? If so, how safe is this?

"One-step" breast cancer treatment, as it's being called, is so new that it is still considered experimental.

The procedure was pioneered four years ago in Britain, where more than 800 women are participating in an international clinical trial. The one-step treatment is also being studied at Princess Margaret Hospital in Toronto.

Technically, the new procedure is known as "intraoperative radiation therapy" and involves delivering a radiation dose to the site of a breast tumor during surgery to destroy any remaining local cancerous tissue. In theory, this can save patients a lot of treatment time, protect the skin, heart and lungs from unnecessary radiation administered externally, and minimize side effects that can occur during conventional radiation treatment given after surgery.

Using a probe attached to a device called the portable intrabeam radiotherapy machine, doctors deliver a single, concentrated dose of radiation. This takes about 30 minutes. The radiation dose used is said to be biologically equivalent to the total amount patients ordinarily would receive on a daily basis for several weeks after recovering from their surgery.

In Canada, the treatment is being used only on patients with small, early stage tumors (less than 2 centimeters).

The new procedure is considered very promising and would certainly be a boon to patients. So far, preliminary results have been encouraging, but it will be two years before doctors in Britain have enough information to confirm that over time "one step" treatment is as effective as current methods. This could turn out to be an exciting development in breast cancer treatment.

Comments

Final lunar eclipse of 2010 set for early morning of December 21

Skygazers hoping to catch the last lunar eclipse of 2010 on Tuesday morning best be ready to stay up late (or wake up very early) to watch the full moon as it goes through a range of dramatic color changes. The December 21 lunar eclipse is expected to last about three-and-a-half hours from its start as a partial eclipse at 1:33 a.m. ET to its finish at 5:01 a.m. ET, according to NASA. The previous lunar eclipse occurred June 26 . During a lunar eclipse, the moon, the Earth, and the sun align so that the sun's rays are shielded from the moon. An eclipse of the moon can only take place if the moon is full, and only if the moon passes through some portion of Earth's shadow, which is composed of two cone-shaped parts, one nested inside the other. The start of the total eclipse is expected around 2:41 a.m, when the entire moon passes through the Earth's umbra, or inner shadow, which blocks all direct sunlight from reaching the moon. The moon will tak...

Hand, Foot and Mouth Disease (HFMD) and Onychomadesis

Introduction Nails are underutilized as diagnostic tools, despite being involved in many dermatologic conditions. This paper explores new concepts in the treatment of median nail dystrophy (MND), onychomycosis, and the nail pathology of hand, foot, and mouth disease (HFMD). A Pubmed database literature search was conducted for MND treatment, onychomycosis treatment, and HFMD nail pathology. Only papers published after January 2008 were reviewed. The results showed that 0.1% tacrolimus ointment can be an effective treatment for MND. Early studies on laser therapy indicate that it is a safe and efficacious treatment option for onychomycosis, compared to conventional oral antifungal agents. Vicks VapoRub (The Proctor & Gamble Company, Cincinnati, OH) is effective against onychomycosis and is a reasonable option in patients who choose to forgo conventional treatments. Lastly, there is evidence to support a correlation between HFMD and onychomadesis. ...

Men With Breast Cancer Face Worse Prognosis

Men who are diagnosed with breast cancer are more likely than female patients to die in the next 15 years, researchers report. "This may be due to a difference in tumor characteristics and treatment," says study leader Hui Miao, a PhD candidate at the National University of Singapore. Male breast cancer is rare, accounting for less than 1% of all breast cancers in the U.S. Given its scarcity, few studies have assessed its prognosis "and we know of no recent studies looking at trends in survival," Miao tells WebMD. So Miao and colleagues studied 459,846 women and 2,664 men diagnosed with breast cancer in Denmark, Finland, Switzerland, Norway, Singapore, and Sweden between 1970 and 2007. Among the findings, presented at the San Antonio Breast Cancer Symposium: Men were diagnosed at an older age: 69 vs. 61 for women. Twice as many men had later stage III or IV disease: 18% vs. 9% of women. Only 25% of men were alive 15 years after diagnosis, compared with 44...

Life, Health and Enjoyment

Search This Blog